Temoporfin

DRUG7 trials

Sponsors

Quintiles, Inc., University of Salzburg, University of Arkansas, Roswell Park Cancer Institute, Chinese University of Hong Kong

Conditions

Carcinoma, Non-Small-Cell-LungCholangiocarcinomaHead and Neck CancerKlatskin TumorNon-curative Resectable Bile Duct CarcinomaRecurrent Non-Small Cell Lung CarcinomaRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Oropharynx

Phase 1

Photodynamic Therapy (PDT) With Temoporfin for Non-Resectable Non-Small-Cell Lung Cancer

WithdrawnNCT01637376

University of ArkansasCarcinoma, Non-Small-Cell-Lung

Start: 2012-07-31End: 2014-01-31Updated: 2014-01-15

Photodynamic Therapy During Surgery in Treating Patients With Non-small Cell Lung Cancer That Can Be Removed by Surgery

CompletedNCT01854684

Roswell Park Cancer InstituteRecurrent Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma, Stage IIB Non-Small Cell Lung Carcinoma +2

Start: 2014-02-21End: 2018-09-04Updated: 2022-07-22

Phase 2

Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy

Quintiles, Inc.Head and Neck Cancer

Start: 1998-10-31Target: 75Updated: 2013-12-19

Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma

University of SalzburgNon-curative Resectable Bile Duct Carcinoma

Start: 2006-01-31Target: 35Updated: 2009-11-18

Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers

TerminatedNCT01415986

University of ArkansasSquamous Cell Carcinoma of the Head and Neck

Start: 2010-11-30End: 2012-03-31Updated: 2012-12-03

Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers

CompletedNCT03003065

Chinese University of Hong KongCholangiocarcinoma, Klatskin Tumor, Tumor

Start: 2014-03-28End: 2023-08-12Updated: 2023-08-22

Unknown Phase

Photodynamic Therapy Using Temoporfin Before Surgery in Treating Patients With Recurrent Oral Cavity or Oropharyngeal Cancer

WithdrawnNCT01718223

Roswell Park Cancer InstituteRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Verrucous Carcinoma of the Oral Cavity +7

Start: 2013-12-31End: 2014-08-31Updated: 2014-09-03

Related Papers

Photodynamic therapy for hilar bile duct cancer: clinical evidence for improved tumoricidal tissue penetration by temoporfin.

2013-04-0417 citations